nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP3A4—Ifosfamide—testicular cancer	0.00586	0.218	CbGbCtD
Rotigotine—CYP1A2—Etoposide—testicular cancer	0.00535	0.199	CbGbCtD
Rotigotine—CYP2D6—Vinblastine—testicular cancer	0.00489	0.182	CbGbCtD
Rotigotine—CYP3A4—Vinblastine—testicular cancer	0.00311	0.115	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—testicular cancer	0.003	0.112	CbGbCtD
Rotigotine—CYP3A4—Etoposide—testicular cancer	0.0028	0.104	CbGbCtD
Rotigotine—Fatigue—Ifosfamide—testicular cancer	0.00209	0.00215	CcSEcCtD
Rotigotine—Hypersensitivity—Bleomycin—testicular cancer	0.00209	0.00215	CcSEcCtD
Rotigotine—Infection—Cisplatin—testicular cancer	0.00208	0.00214	CcSEcCtD
Rotigotine—Pain—Ifosfamide—testicular cancer	0.00207	0.00213	CcSEcCtD
Rotigotine—Constipation—Ifosfamide—testicular cancer	0.00207	0.00213	CcSEcCtD
Rotigotine—Loss of consciousness—Etoposide—testicular cancer	0.00206	0.00212	CcSEcCtD
Rotigotine—Lethargy—Doxorubicin—testicular cancer	0.00206	0.00212	CcSEcCtD
Rotigotine—Nervous system disorder—Cisplatin—testicular cancer	0.00205	0.00211	CcSEcCtD
Rotigotine—Cough—Etoposide—testicular cancer	0.00205	0.00211	CcSEcCtD
Rotigotine—Asthenia—Bleomycin—testicular cancer	0.00204	0.00209	CcSEcCtD
Rotigotine—Skin disorder—Cisplatin—testicular cancer	0.00203	0.00209	CcSEcCtD
Rotigotine—Hypertension—Etoposide—testicular cancer	0.00203	0.00208	CcSEcCtD
Rotigotine—Hyperhidrosis—Cisplatin—testicular cancer	0.00202	0.00208	CcSEcCtD
Rotigotine—Pruritus—Bleomycin—testicular cancer	0.00201	0.00206	CcSEcCtD
Rotigotine—Feeling abnormal—Ifosfamide—testicular cancer	0.002	0.00205	CcSEcCtD
Rotigotine—Nausea—Vinblastine—testicular cancer	0.002	0.00205	CcSEcCtD
Rotigotine—Orthostatic hypotension—Epirubicin—testicular cancer	0.002	0.00205	CcSEcCtD
Rotigotine—Anorexia—Cisplatin—testicular cancer	0.00199	0.00205	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00199	0.00204	CcSEcCtD
Rotigotine—Discomfort—Etoposide—testicular cancer	0.00198	0.00203	CcSEcCtD
Rotigotine—Breast disorder—Epirubicin—testicular cancer	0.00198	0.00203	CcSEcCtD
Rotigotine—Hypotension—Cisplatin—testicular cancer	0.00195	0.00201	CcSEcCtD
Rotigotine—Nasopharyngitis—Epirubicin—testicular cancer	0.00195	0.00201	CcSEcCtD
Rotigotine—Hypersensitivity—Dactinomycin—testicular cancer	0.00195	0.002	CcSEcCtD
Rotigotine—Confusional state—Etoposide—testicular cancer	0.00193	0.00199	CcSEcCtD
Rotigotine—Urticaria—Ifosfamide—testicular cancer	0.00193	0.00198	CcSEcCtD
Rotigotine—CYP3A4—Doxorubicin—testicular cancer	0.00191	0.0709	CbGbCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00191	0.00196	CcSEcCtD
Rotigotine—Infection—Etoposide—testicular cancer	0.0019	0.00196	CcSEcCtD
Rotigotine—Asthenia—Dactinomycin—testicular cancer	0.0019	0.00195	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—testicular cancer	0.00188	0.00193	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00188	0.00193	CcSEcCtD
Rotigotine—Skin disorder—Etoposide—testicular cancer	0.00186	0.00191	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—testicular cancer	0.00186	0.00191	CcSEcCtD
Rotigotine—Hyperhidrosis—Etoposide—testicular cancer	0.00185	0.0019	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00185	0.0019	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—testicular cancer	0.00183	0.00188	CcSEcCtD
Rotigotine—Anorexia—Etoposide—testicular cancer	0.00183	0.00188	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—testicular cancer	0.00182	0.00187	CcSEcCtD
Rotigotine—Diarrhoea—Dactinomycin—testicular cancer	0.00181	0.00186	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—testicular cancer	0.00181	0.00186	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00181	0.00186	CcSEcCtD
Rotigotine—Vomiting—Bleomycin—testicular cancer	0.00181	0.00186	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—testicular cancer	0.0018	0.00185	CcSEcCtD
Rotigotine—Infestation—Methotrexate—testicular cancer	0.0018	0.00185	CcSEcCtD
Rotigotine—Depression—Methotrexate—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Hypotension—Etoposide—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Rash—Bleomycin—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Pain—Cisplatin—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Dermatitis—Bleomycin—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Hypersensitivity—Ifosfamide—testicular cancer	0.00179	0.00184	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00176	0.0018	CcSEcCtD
Rotigotine—Asthenia—Ifosfamide—testicular cancer	0.00174	0.00179	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—testicular cancer	0.00172	0.00177	CcSEcCtD
Rotigotine—Paraesthesia—Etoposide—testicular cancer	0.00172	0.00177	CcSEcCtD
Rotigotine—Weight increased—Epirubicin—testicular cancer	0.00172	0.00177	CcSEcCtD
Rotigotine—Pruritus—Ifosfamide—testicular cancer	0.00172	0.00176	CcSEcCtD
Rotigotine—Weight decreased—Epirubicin—testicular cancer	0.00171	0.00176	CcSEcCtD
Rotigotine—Somnolence—Etoposide—testicular cancer	0.0017	0.00175	CcSEcCtD
Rotigotine—Nausea—Bleomycin—testicular cancer	0.00169	0.00173	CcSEcCtD
Rotigotine—Infestation NOS—Epirubicin—testicular cancer	0.00168	0.00173	CcSEcCtD
Rotigotine—Infestation—Epirubicin—testicular cancer	0.00168	0.00173	CcSEcCtD
Rotigotine—Vomiting—Dactinomycin—testicular cancer	0.00168	0.00173	CcSEcCtD
Rotigotine—Rash—Dactinomycin—testicular cancer	0.00167	0.00172	CcSEcCtD
Rotigotine—Decreased appetite—Etoposide—testicular cancer	0.00167	0.00171	CcSEcCtD
Rotigotine—Diarrhoea—Ifosfamide—testicular cancer	0.00166	0.00171	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00165	0.0017	CcSEcCtD
Rotigotine—Fatigue—Etoposide—testicular cancer	0.00165	0.0017	CcSEcCtD
Rotigotine—Pain—Etoposide—testicular cancer	0.00164	0.00168	CcSEcCtD
Rotigotine—Constipation—Etoposide—testicular cancer	0.00164	0.00168	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00162	0.00167	CcSEcCtD
Rotigotine—Dizziness—Ifosfamide—testicular cancer	0.0016	0.00165	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—testicular cancer	0.00159	0.00163	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—testicular cancer	0.00158	0.00163	CcSEcCtD
Rotigotine—Sinusitis—Epirubicin—testicular cancer	0.00158	0.00162	CcSEcCtD
Rotigotine—Feeling abnormal—Etoposide—testicular cancer	0.00158	0.00162	CcSEcCtD
Rotigotine—Nausea—Dactinomycin—testicular cancer	0.00157	0.00162	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—testicular cancer	0.00156	0.0016	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—testicular cancer	0.00156	0.0016	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—testicular cancer	0.00156	0.0016	CcSEcCtD
Rotigotine—Vomiting—Ifosfamide—testicular cancer	0.00154	0.00159	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—testicular cancer	0.00154	0.00158	CcSEcCtD
Rotigotine—Rash—Ifosfamide—testicular cancer	0.00153	0.00157	CcSEcCtD
Rotigotine—Dermatitis—Ifosfamide—testicular cancer	0.00153	0.00157	CcSEcCtD
Rotigotine—Urticaria—Etoposide—testicular cancer	0.00152	0.00156	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—testicular cancer	0.00151	0.00155	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—testicular cancer	0.0015	0.00154	CcSEcCtD
Rotigotine—Oedema peripheral—Epirubicin—testicular cancer	0.00149	0.00153	CcSEcCtD
Rotigotine—Connective tissue disorder—Epirubicin—testicular cancer	0.00149	0.00153	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—testicular cancer	0.00147	0.00151	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—testicular cancer	0.00146	0.0015	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—testicular cancer	0.00146	0.0015	CcSEcCtD
Rotigotine—Visual impairment—Epirubicin—testicular cancer	0.00146	0.0015	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—testicular cancer	0.00146	0.0015	CcSEcCtD
Rotigotine—Nausea—Ifosfamide—testicular cancer	0.00144	0.00148	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—testicular cancer	0.00143	0.00147	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—testicular cancer	0.00142	0.00145	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—testicular cancer	0.00141	0.00145	CcSEcCtD
Rotigotine—Tinnitus—Epirubicin—testicular cancer	0.00141	0.00145	CcSEcCtD
Rotigotine—Erythema—Methotrexate—testicular cancer	0.00141	0.00145	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—testicular cancer	0.00141	0.00145	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—testicular cancer	0.00138	0.00142	CcSEcCtD
Rotigotine—Asthenia—Etoposide—testicular cancer	0.00137	0.00141	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—testicular cancer	0.00137	0.00141	CcSEcCtD
Rotigotine—Angiopathy—Epirubicin—testicular cancer	0.00137	0.00141	CcSEcCtD
Rotigotine—Immune system disorder—Epirubicin—testicular cancer	0.00137	0.0014	CcSEcCtD
Rotigotine—Mediastinal disorder—Epirubicin—testicular cancer	0.00136	0.0014	CcSEcCtD
Rotigotine—Pruritus—Etoposide—testicular cancer	0.00136	0.00139	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—testicular cancer	0.00135	0.00139	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—testicular cancer	0.00133	0.00137	CcSEcCtD
Rotigotine—Mental disorder—Epirubicin—testicular cancer	0.00132	0.00136	CcSEcCtD
Rotigotine—Rash—Cisplatin—testicular cancer	0.00132	0.00136	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—testicular cancer	0.00132	0.00135	CcSEcCtD
Rotigotine—Erythema—Epirubicin—testicular cancer	0.00132	0.00135	CcSEcCtD
Rotigotine—Malnutrition—Epirubicin—testicular cancer	0.00132	0.00135	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—testicular cancer	0.00131	0.00135	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—testicular cancer	0.00131	0.00134	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—testicular cancer	0.0013	0.00134	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—testicular cancer	0.00127	0.0013	CcSEcCtD
Rotigotine—Malaise—Methotrexate—testicular cancer	0.00127	0.0013	CcSEcCtD
Rotigotine—Dizziness—Etoposide—testicular cancer	0.00127	0.0013	CcSEcCtD
Rotigotine—Muscle spasms—Epirubicin—testicular cancer	0.00127	0.0013	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—testicular cancer	0.00126	0.0013	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—testicular cancer	0.00126	0.0013	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—testicular cancer	0.00126	0.0013	CcSEcCtD
Rotigotine—Nausea—Cisplatin—testicular cancer	0.00124	0.00128	CcSEcCtD
Rotigotine—Cough—Methotrexate—testicular cancer	0.00123	0.00126	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—testicular cancer	0.00123	0.00126	CcSEcCtD
Rotigotine—Ill-defined disorder—Epirubicin—testicular cancer	0.00122	0.00126	CcSEcCtD
Rotigotine—Vomiting—Etoposide—testicular cancer	0.00122	0.00125	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—testicular cancer	0.00122	0.00125	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—testicular cancer	0.00122	0.00125	CcSEcCtD
Rotigotine—Agitation—Epirubicin—testicular cancer	0.00121	0.00124	CcSEcCtD
Rotigotine—Rash—Etoposide—testicular cancer	0.00121	0.00124	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—testicular cancer	0.00121	0.00124	CcSEcCtD
Rotigotine—Headache—Etoposide—testicular cancer	0.0012	0.00123	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—testicular cancer	0.0012	0.00123	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00119	0.00122	CcSEcCtD
Rotigotine—Malaise—Epirubicin—testicular cancer	0.00119	0.00122	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—testicular cancer	0.00118	0.00122	CcSEcCtD
Rotigotine—Vertigo—Epirubicin—testicular cancer	0.00118	0.00122	CcSEcCtD
Rotigotine—Syncope—Epirubicin—testicular cancer	0.00118	0.00121	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—testicular cancer	0.00117	0.0012	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—testicular cancer	0.00116	0.00119	CcSEcCtD
Rotigotine—Loss of consciousness—Epirubicin—testicular cancer	0.00116	0.00119	CcSEcCtD
Rotigotine—Cough—Epirubicin—testicular cancer	0.00115	0.00118	CcSEcCtD
Rotigotine—Infection—Methotrexate—testicular cancer	0.00114	0.00117	CcSEcCtD
Rotigotine—Nausea—Etoposide—testicular cancer	0.00114	0.00117	CcSEcCtD
Rotigotine—Hypertension—Epirubicin—testicular cancer	0.00114	0.00117	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—testicular cancer	0.00113	0.00116	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—testicular cancer	0.00113	0.00116	CcSEcCtD
Rotigotine—Arthralgia—Epirubicin—testicular cancer	0.00112	0.00115	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—testicular cancer	0.00112	0.00115	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—testicular cancer	0.00111	0.00115	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00111	0.00114	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—testicular cancer	0.00111	0.00114	CcSEcCtD
Rotigotine—Discomfort—Epirubicin—testicular cancer	0.00111	0.00114	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Rotigotine—Dry mouth—Epirubicin—testicular cancer	0.0011	0.00113	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—testicular cancer	0.00109	0.00112	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—testicular cancer	0.00109	0.00112	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—testicular cancer	0.00109	0.00112	CcSEcCtD
Rotigotine—Confusional state—Epirubicin—testicular cancer	0.00108	0.00111	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—testicular cancer	0.00107	0.0011	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—testicular cancer	0.00107	0.0011	CcSEcCtD
Rotigotine—Infection—Epirubicin—testicular cancer	0.00107	0.0011	CcSEcCtD
Rotigotine—Cough—Doxorubicin—testicular cancer	0.00106	0.00109	CcSEcCtD
Rotigotine—Shock—Epirubicin—testicular cancer	0.00106	0.00109	CcSEcCtD
Rotigotine—Nervous system disorder—Epirubicin—testicular cancer	0.00105	0.00108	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—testicular cancer	0.00105	0.00108	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00105	0.00107	CcSEcCtD
Rotigotine—Skin disorder—Epirubicin—testicular cancer	0.00104	0.00107	CcSEcCtD
Rotigotine—Hyperhidrosis—Epirubicin—testicular cancer	0.00104	0.00107	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—testicular cancer	0.00104	0.00107	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—testicular cancer	0.00104	0.00107	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—testicular cancer	0.00103	0.00106	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00103	0.00106	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—testicular cancer	0.00102	0.00105	CcSEcCtD
Rotigotine—Anorexia—Epirubicin—testicular cancer	0.00102	0.00105	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—testicular cancer	0.00102	0.00105	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—testicular cancer	0.00101	0.00104	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—testicular cancer	0.00101	0.00104	CcSEcCtD
Rotigotine—Hypotension—Epirubicin—testicular cancer	0.001	0.00103	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—testicular cancer	0.001	0.00103	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—testicular cancer	0.000998	0.00103	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000991	0.00102	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—testicular cancer	0.00099	0.00102	CcSEcCtD
Rotigotine—Infection—Doxorubicin—testicular cancer	0.000987	0.00101	CcSEcCtD
Rotigotine—Pain—Methotrexate—testicular cancer	0.000982	0.00101	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000979	0.00101	CcSEcCtD
Rotigotine—Shock—Doxorubicin—testicular cancer	0.000978	0.001	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—testicular cancer	0.000975	0.001	CcSEcCtD
Rotigotine—Insomnia—Epirubicin—testicular cancer	0.000972	0.000999	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—testicular cancer	0.000965	0.000992	CcSEcCtD
Rotigotine—Paraesthesia—Epirubicin—testicular cancer	0.000965	0.000991	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000961	0.000988	CcSEcCtD
Rotigotine—Somnolence—Epirubicin—testicular cancer	0.000955	0.000981	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—testicular cancer	0.000947	0.000974	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—testicular cancer	0.000946	0.000972	CcSEcCtD
Rotigotine—Dyspepsia—Epirubicin—testicular cancer	0.000946	0.000972	CcSEcCtD
Rotigotine—Decreased appetite—Epirubicin—testicular cancer	0.000934	0.00096	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—testicular cancer	0.000929	0.000955	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000927	0.000953	CcSEcCtD
Rotigotine—Fatigue—Epirubicin—testicular cancer	0.000926	0.000952	CcSEcCtD
Rotigotine—Constipation—Epirubicin—testicular cancer	0.000919	0.000944	CcSEcCtD
Rotigotine—Pain—Epirubicin—testicular cancer	0.000919	0.000944	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—testicular cancer	0.000912	0.000937	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000906	0.000931	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—testicular cancer	0.000899	0.000924	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—testicular cancer	0.000893	0.000917	CcSEcCtD
Rotigotine—Feeling abnormal—Epirubicin—testicular cancer	0.000885	0.00091	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—testicular cancer	0.000884	0.000908	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—testicular cancer	0.000875	0.000899	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—testicular cancer	0.000864	0.000888	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000858	0.000882	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—testicular cancer	0.000857	0.000881	CcSEcCtD
Rotigotine—Urticaria—Epirubicin—testicular cancer	0.000853	0.000877	CcSEcCtD
Rotigotine—Pain—Doxorubicin—testicular cancer	0.00085	0.000874	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—testicular cancer	0.00085	0.000874	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—testicular cancer	0.000846	0.000869	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—testicular cancer	0.000824	0.000846	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—testicular cancer	0.000819	0.000842	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—testicular cancer	0.000812	0.000835	CcSEcCtD
Rotigotine—Hypersensitivity—Epirubicin—testicular cancer	0.000791	0.000813	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—testicular cancer	0.00079	0.000811	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—testicular cancer	0.000785	0.000807	CcSEcCtD
Rotigotine—Asthenia—Epirubicin—testicular cancer	0.000771	0.000792	CcSEcCtD
Rotigotine—Pruritus—Epirubicin—testicular cancer	0.00076	0.000781	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—testicular cancer	0.000759	0.00078	CcSEcCtD
Rotigotine—Diarrhoea—Epirubicin—testicular cancer	0.000735	0.000755	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—testicular cancer	0.000732	0.000753	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—testicular cancer	0.00073	0.00075	CcSEcCtD
Rotigotine—Rash—Methotrexate—testicular cancer	0.000724	0.000744	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—testicular cancer	0.000723	0.000743	CcSEcCtD
Rotigotine—Headache—Methotrexate—testicular cancer	0.000719	0.000739	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—testicular cancer	0.000713	0.000733	CcSEcCtD
Rotigotine—Dizziness—Epirubicin—testicular cancer	0.00071	0.00073	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—testicular cancer	0.000703	0.000723	CcSEcCtD
Rotigotine—Vomiting—Epirubicin—testicular cancer	0.000683	0.000702	CcSEcCtD
Rotigotine—Nausea—Methotrexate—testicular cancer	0.000682	0.000701	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—testicular cancer	0.00068	0.000699	CcSEcCtD
Rotigotine—Rash—Epirubicin—testicular cancer	0.000677	0.000696	CcSEcCtD
Rotigotine—Dermatitis—Epirubicin—testicular cancer	0.000677	0.000695	CcSEcCtD
Rotigotine—Headache—Epirubicin—testicular cancer	0.000673	0.000692	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—testicular cancer	0.000657	0.000675	CcSEcCtD
Rotigotine—Nausea—Epirubicin—testicular cancer	0.000638	0.000656	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—testicular cancer	0.000632	0.000649	CcSEcCtD
Rotigotine—Rash—Doxorubicin—testicular cancer	0.000627	0.000644	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—testicular cancer	0.000626	0.000643	CcSEcCtD
Rotigotine—Headache—Doxorubicin—testicular cancer	0.000623	0.00064	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—testicular cancer	0.00059	0.000607	CcSEcCtD
